32631441|t|Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage.
32631441|a|Cerebral amyloid angiopathy (CAA) is characterized by the deposition of the amyloid beta (Abeta) protein in the cerebral vasculature and poses a major risk factor for the development of intracerebral haemorrhages (ICH). However, only a minority of patients with CAA develops ICH (CAA-ICH), and to date it is unclear which mechanisms determine why some patients with CAA are more susceptible to haemorrhage than others. We hypothesized that an imbalance between matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) contributes to vessel wall weakening. MMP9 plays a role in the degradation of various components of the extracellular matrix as well as of Abeta and increased MMP9 expression has been previously associated with CAA. TIMP3 is an inhibitor of MMP9 and increased TIMP3 expression in cerebral vessels has also been associated with CAA. In this study, we investigated the expression of MMP9 and TIMP3 in occipital brain tissue of CAA-ICH cases (n = 11) by immunohistochemistry and compared this to the expression in brain tissue of CAA cases without ICH (CAA-non-haemorrhagic, CAA-NH, n = 18). We showed that MMP9 expression is increased in CAA-ICH cases compared to CAA-NH cases. Furthermore, we showed that TIMP3 expression is increased in CAA cases compared to controls without CAA, and that TIMP3 expression is reduced in a subset of CAA-ICH cases compared to CAA-NH cases. In conclusion, in patients with CAA, a disbalance in cerebrovascular MMP9 and TIMP3 expression is associated with CAA-related ICH.
32631441	39	43	MMP9	Gene	4318
32631441	48	53	TIMP3	Gene	7078
32631441	57	84	cerebral amyloid angiopathy	Disease	MESH:D016657
32631441	93	118	intracerebral haemorrhage	Disease	MESH:D002543
32631441	120	147	Cerebral amyloid angiopathy	Disease	MESH:D016657
32631441	149	152	CAA	Disease	MESH:D016657
32631441	196	208	amyloid beta	Gene	351
32631441	210	215	Abeta	Gene	351
32631441	306	332	intracerebral haemorrhages	Disease	MESH:D002543
32631441	334	337	ICH	Disease	MESH:D002543
32631441	368	376	patients	Species	9606
32631441	382	385	CAA	Disease	MESH:D016657
32631441	395	398	ICH	Disease	MESH:D002543
32631441	400	403	CAA	Disease	MESH:D016657
32631441	404	407	ICH	Disease	MESH:D002543
32631441	472	480	patients	Species	9606
32631441	486	489	CAA	Disease	MESH:D016657
32631441	514	525	haemorrhage	Disease	MESH:D006470
32631441	681	685	MMP9	Gene	4318
32631441	782	787	Abeta	Gene	351
32631441	802	806	MMP9	Gene	4318
32631441	854	857	CAA	Disease	MESH:D016657
32631441	859	864	TIMP3	Gene	7078
32631441	884	888	MMP9	Gene	4318
32631441	903	908	TIMP3	Gene	7078
32631441	970	973	CAA	Disease	MESH:D016657
32631441	1024	1028	MMP9	Gene	4318
32631441	1033	1038	TIMP3	Gene	7078
32631441	1068	1071	CAA	Disease	MESH:D016657
32631441	1072	1075	ICH	Disease	MESH:D002543
32631441	1170	1173	CAA	Disease	MESH:D016657
32631441	1188	1191	ICH	Disease	MESH:D002543
32631441	1193	1196	CAA	Disease	MESH:D016657
32631441	1215	1218	CAA	Disease	MESH:D016657
32631441	1247	1251	MMP9	Gene	4318
32631441	1279	1282	CAA	Disease	MESH:D016657
32631441	1283	1286	ICH	Disease	MESH:D002543
32631441	1305	1308	CAA	Disease	MESH:D016657
32631441	1347	1352	TIMP3	Gene	7078
32631441	1380	1383	CAA	Disease	MESH:D016657
32631441	1419	1422	CAA	Disease	MESH:D016657
32631441	1433	1438	TIMP3	Gene	7078
32631441	1476	1479	CAA	Disease	MESH:D016657
32631441	1480	1483	ICH	Disease	MESH:D002543
32631441	1502	1505	CAA	Disease	MESH:D016657
32631441	1534	1542	patients	Species	9606
32631441	1548	1551	CAA	Disease	MESH:D016657
32631441	1585	1589	MMP9	Gene	4318
32631441	1594	1599	TIMP3	Gene	7078
32631441	1630	1633	CAA	Disease	MESH:D016657
32631441	1642	1645	ICH	Disease	MESH:D002543
32631441	Association	MESH:D016657	351
32631441	Association	MESH:D002543	4318
32631441	Negative_Correlation	4318	7078
32631441	Association	MESH:D016657	4318
32631441	Association	MESH:D016657	7078
32631441	Negative_Correlation	MESH:D002543	7078
32631441	Association	351	4318

